In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Apellis Pharmaceuticals Inc (NASDAQ: APLS) closed at $18.95 in the last session, up 1.07% from day before closing price of $18.75. In other words, the price has increased by $1.07 from its previous closing price. On the day, 5.51 million shares were traded. APLS stock price reached its highest trading level at $19.45 during the session, while it also had its lowest trading level at $18.48.
Ratios:
We take a closer look at APLS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 4.08. In the meantime, Its Debt-to-Equity ratio is 2.86 whereas as Long-Term Debt/Eq ratio is at 2.82.
On May 09, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $23.
On April 29, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $44.Cantor Fitzgerald initiated its Overweight rating on April 29, 2025, with a $44 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 17 ’25 when Francois Cedric sold 19,725 shares for $20.21 per share. The transaction valued at 398,735 led to the insider holds 331,605 shares of the business.
Watson David O. sold 5,000 shares of APLS for $97,750 on Jul 16 ’25. The General Counsel now owns 128,730 shares after completing the transaction at $19.55 per share. On Jul 17 ’25, another insider, Francois Cedric, who serves as the Officer of the company, bought 19,725 shares for $20.15 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLS now has a Market Capitalization of 2381673984 and an Enterprise Value of 2488895744. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.07 while its Price-to-Book (P/B) ratio in mrq is 14.50. Its current Enterprise Value per Revenue stands at 3.208 whereas that against EBITDA is -13.496.
Stock Price History:
The Beta on a monthly basis for APLS is 0.76, which has changed by -0.52146465 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, APLS has reached a high of $41.94, while it has fallen to a 52-week low of $16.10. The 50-Day Moving Average of the stock is 2.19%, while the 200-Day Moving Average is calculated to be -23.37%.
Shares Statistics:
According to the various share statistics, APLS traded on average about 2.43M shares per day over the past 3-months and 2615930 shares per day over the past 10 days. A total of 125.66M shares are outstanding, with a floating share count of 103.40M. Insiders hold about 17.73% of the company’s shares, while institutions hold 99.97% stake in the company. Shares short for APLS as of 1752537600 were 16492598 with a Short Ratio of 6.79, compared to 1749772800 on 25140355. Therefore, it implies a Short% of Shares Outstanding of 16492598 and a Short% of Float of 17.31.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
